
Company Info
Year Established2021
Contacts
Andre TurennePresident & CEO
Jared Cumming, PhD
CSO
Christopher Hren
VP, Corporate Development & Operations
Company Description
Matchpoint is discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.